Abstract
Recently, CRISPR-based techniques have significantly improved our ability to make desired changes and regulations in various genomes. Among them, targeted base editing is one of the most powerful techniques in making precise genomic editing. Base editing enabled the irreversible conversion of a specific single DNA base, from C to T or and from A to G, in desired genomic loci. This technique has important implications in the study of human genetic diseases, considering that many of them resulted from point mutations. More importantly, the high efficiency of these editing tools also provided great promise in clinical applications. In this review, we discuss the recent progress and challenges of base editing tools.
Keywords: CRISPR based techniques, genomes, targeted base editing, human genetic diseases, point mutations, base editing tools.
Current Gene Therapy
Title:Recent Advances in CRISPR/Cas9 Directed Base Editing
Volume: 21 Issue: 4
Author(s): Nan Liu, Lifang Zhou, Junyan Qu and Shaohua Yao*
Affiliation:
- Laboratory of Biotherapy, National Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Renmin Nanlu 17, Chengdu 610041, Sichuan,China
Keywords: CRISPR based techniques, genomes, targeted base editing, human genetic diseases, point mutations, base editing tools.
Abstract: Recently, CRISPR-based techniques have significantly improved our ability to make desired changes and regulations in various genomes. Among them, targeted base editing is one of the most powerful techniques in making precise genomic editing. Base editing enabled the irreversible conversion of a specific single DNA base, from C to T or and from A to G, in desired genomic loci. This technique has important implications in the study of human genetic diseases, considering that many of them resulted from point mutations. More importantly, the high efficiency of these editing tools also provided great promise in clinical applications. In this review, we discuss the recent progress and challenges of base editing tools.
Export Options
About this article
Cite this article as:
Liu Nan , Zhou Lifang , Qu Junyan and Yao Shaohua *, Recent Advances in CRISPR/Cas9 Directed Base Editing, Current Gene Therapy 2021; 21 (4) . https://dx.doi.org/10.2174/1566523221666210322090638
DOI https://dx.doi.org/10.2174/1566523221666210322090638 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Telomeres and Thyroid Cancer
Current Genomics Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Current Drug Targets Ellipticines as DNA-Targeted Chemotherapeutics
Current Medicinal Chemistry The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment
Current Pharmaceutical Design Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
Current Topics in Medicinal Chemistry Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Meet the Editorial Board:
Recent Patents on Anti-Cancer Drug Discovery Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
Current Medicinal Chemistry Recent Mass Spectrometric Based Methods in Quantitative N-linked Glycoproteomics
Current Proteomics Major Developments in the Design of Inhibitors along the Kynurenine Pathway
Current Medicinal Chemistry Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art
Current Cancer Therapy Reviews IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Current Drug Targets Cancer Therapeutics: Emerging Targets and Trends
Current Cancer Therapy Reviews Combined Therapies of Bone Disease with Bisphosphonates
Current Pharmaceutical Design Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases
Current Molecular Pharmacology Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Melatonin, its Metabolites and its Synthetic Analogs as Multi-Faceted Compounds: Antioxidant, Prooxidant and Inhibitor of Bioactivation Reactions
Current Medicinal Chemistry TRAIL: A Sword for Killing Tumors
Current Medicinal Chemistry Substrate Specificity of Rat DESC4, a Type II Transmembrane Serine Protease
Protein & Peptide Letters